Canadian Journal of Infectious Diseases and Medical Microbiology (Jan 2013)

The Impact of Serum Vancomycin Levels and Minimum Inhibitory Concentrations of Methicillin-Resistant Staphylococcus aureus on Mortality in Patients with Nosocomial Pneumonia

  • Denise Pires Machado,
  • Luciano Z Goldani,
  • Rodrigo Minuto Paiva,
  • Valério Rodrigues Aquino,
  • Fernanda de-Paris,
  • Thiago Lisboa,
  • Bruno Jung,
  • Rodrigo Pires dos Santos

DOI
https://doi.org/10.1155/2013/585834
Journal volume & issue
Vol. 24, no. 3
pp. e75 – e79

Abstract

Read online

BACKGROUND: Vancomycin is the treatment of choice for methicillin-resistant Staphylococcus aureus (MRSA) infections; however, treatment failure is not uncommon, even when the minimum inhibitory concentration (MIC) of the MRSA strain is within the susceptible range for vancomycin.